Japanese Encephalitis Virus Testing: CSF is Superior to Serum
For Japanese encephalitis virus (JEV) testing, cerebrospinal fluid (CSF) should be the preferred specimen, as JEV-specific IgM antibodies are detectable earlier and more reliably in CSF throughout the disease course compared to serum.
Diagnostic Algorithm
Primary Testing Approach
CSF IgM testing is the gold standard for JE diagnosis, particularly in the acute phase 1. The evidence clearly demonstrates:
- CSF IgM detection: Positive in 91% (60/66) of samples collected on days 1-4 of illness, and nearly 100% of samples from day 7 onward 2
- Serum IgM detection: Only 59% (26/44) positive on days 1-4, reaching reliable levels only after day 9 of illness 2
This temporal difference is critical—CSF testing provides diagnostic confirmation approximately 5 days earlier than serum testing 2.
When to Test Both Specimens
The International Encephalitis Consortium guidelines recommend testing both CSF and serum when possible 1. This dual approach is valuable because:
- Serum RT-PCR may detect virus during the first few days when IgM antibodies haven't yet developed (83.3% positivity vs 66.7% for CSF alone) 3
- Combined testing increases overall diagnostic yield to 86.1% 3
- Serum testing serves as a backup when CSF cannot be safely obtained
Critical Caveat: Cross-Reactivity Issues
A major pitfall is flavivirus cross-reactivity, particularly with dengue virus (DENV) and West Nile virus (WNV) 4, 5. When JEV IgM is positive:
- Confirmatory testing is essential using plaque reduction neutralization tests (PRNT) 4
- Sequential testing with both JE and dengue MAC-ELISA kits can improve specificity in serum, but paradoxically reduces specificity in CSF because true JEV-positive CSF samples may test positive for both assays 5
- This cross-reactivity problem is particularly relevant in regions where multiple flaviviruses co-circulate
Practical Testing Strategy
First-line: Obtain CSF for IgM testing via MAC-ELISA—this provides the earliest and most reliable diagnosis 2
Add serum testing if:
- Patient presents within first 4 days of illness (to capture viremia via RT-PCR) 3
- CSF cannot be safely obtained
- Initial CSF IgM is negative but clinical suspicion remains high
Confirm positive results with PRNT at a reference laboratory, especially in areas with multiple endemic flaviviruses 4, 5
Consider emerging methods: Metagenomic next-generation sequencing (mNGS) of CSF can provide rapid identification when conventional methods are delayed or negative 6
Why CSF is Superior
The biological basis for CSF superiority relates to the pathophysiology of JE—JEV directly invades the central nervous system, causing localized antibody production in the CSF that appears earlier and persists more reliably than systemic antibody responses 2. By contrast, viremia is typically brief and low-magnitude, often resolving before symptom onset 1, 7.